期刊文献+

不同浓度淫羊藿含药血清干预骨髓基质干细胞的成脂分化 被引量:18

Adipogenic differentiation of bone marrow stromal stem cells intervened with serum containing different concentration Epimedium
下载PDF
导出
摘要 背景:如何抑制骨髓基质干细胞成脂分化,促进其成骨分化将是防治骨质疏松的新途径之一。目的:观察不同浓度淫羊藿含药血清对骨质疏松大鼠骨髓基质干细胞成脂分化的干预作用。方法:全骨髓培养法培养SD大鼠骨髓间充质干细胞,12只SPF级SD雌性大鼠按体表面积的方法给予淫羊藿水提液,药物以蒸馏水定容至所需浓度,相当于临床剂量的20倍、10倍、5倍灌胃,连续灌胃7d后眼眶取血,观察各组干预后7d成脂分化情况。结果与结论:中药低、中剂量含药血清组的成脂率低于空白组(P<0.01、0.05),说明中药淫羊藿含药血清发挥了抑制骨质疏松骨髓基质干细胞向脂肪细胞分化的作用。中药各剂量组的组间比较差异无显著性意义(P>0.05),但3组成脂率数值方面以中剂量组最佳。 BACKGROUND:How to inhibit adipogenic differentiation of bone marrow stromal stem cells(BMSCs) and promote the osteogenic differentiation of BMSCs is a new approach to prevention and treatment of osteoporosis.OBJECTIVE:To investigate the effect of serum containing different concentration Epimedium on adipogenic differentiation of BMSCs in rats with osteoporosis.METHODS:Three of 15 SPF-class SD female rats were used to isolate and culture BMSCs.The remaining 12 rats were divided into control group,high dose herb group,medium dose herb group,low dose herb group.Adipogenic differentiation was observed after 7 day's intervention.RESULTS AND CONCLUSION:Medium and low dose herb groups played the effects on suppressing adipogenic differentiation of BMSCs(P0.01,0.05).There was no significant difference among each herb groups(P0.05).The medium dose herb was the best in different concentration dose herb on inhibiting adipogenic differentiation of BMSCs.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第14期2583-2586,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家自然科学基金资助项目(30901915) 中国博士后科学基金面上资助项目(20080440744)~~
  • 相关文献

参考文献20

  • 1Clavin NW,Fernandez J,Sch?nmeyr BH,et al.Fractionated doses of ionizing radiation confer protection to mesenchymal stem cell pluripotency.Plast Reconstr Surg.2008;122(3):739-748.
  • 2Gnecchi M,Melo LG.Bone marrow-derived mesenchymal stem cells:isolation,expansion,characterization,viral transduction,and production of conditioned medium.Methods Mol Biol.2009; 482:281-294.
  • 3Aurich I,Mueller LP,Aurich H,et al.Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.Gut.2007;56(3):405-415.
  • 4Nuttall ME,Gimble JM.Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone.2000;27(2):177-184.
  • 5鞠大宏,于福禄,张丽坤,于智敏,赵宏艳,刘梅洁,张立石,刘红,潘静华,王少君.滋阴补肾法对卵巢切除所致骨质疏松大鼠成骨细胞COX-2蛋白和mRNA表达的影响[J].中国中医基础医学杂志,2006,12(12):918-920. 被引量:30
  • 6Deans RJ,Moseley AB.Mesenchymal stem cells:biology and potential clinical uses.Exp Hematol.2000;28(8):875-884.
  • 7Pittenger MF,Mackay AM,Beck SC,et al.Multilineage potential of adult human mesenchymal stem cells.Science.1999;284(5411):143-147.
  • 8Kha HT,Basseri B,Shouhed D,et al.Oxysterols regulate differentiation of mesenchymal stem cells:pro-bone and anti-fat.J Bone Miner Res.2004;19(5):830-840.
  • 9朱蕾,赵小英,卢兴国.去卵巢大鼠骨密度变化与骨髓组织血管生成的关系[J].中国病理生理杂志,2009,25(9):1801-1805. 被引量:16
  • 10Lazarenko OP,Rzonca SO,Hogue WR,et al.Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.Endocrinology.2007;148(6):2669-2680.

二级参考文献99

共引文献274

同被引文献210

引证文献18

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部